Protective effect of rotavirus VP-6 specific IgA monoclonal antibodies that lack neutralizing activity.
Taminiau
J A
JA
Pediatric Gastroenterology, University of Amsterdam, The Netherlands.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000956:Antigens, Viral / Q000276:immunology*; D002213:Capsid / Q000276:immunology; D036022:Capsid Proteins; D007070:Immunoglobulin A / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000517:prevention & control*
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral; D036022:Capsid Proteins; D007070:Immunoglobulin A; C061332:VP6 protein, Rotavirus